| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |